FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry. A liquid pharmaceutical composition containing cyclosporine, an aqueous liquid carrier, a first solubility-enabling substance selected from a group of phospholipids and a second solubility-enabling substance selected from a group of non-ionic surface-active substances, and a phospholipid represents a mixture of natural phospholipids and contains cyclosporine in a liposomally solubilised form. A method of producing the composition. Application of the composition. A container containing the composition. A method of filling the container with the composition. Method of producing an aerosol.
EFFECT: composition described above is stable and effective for oral, parenteral, nasal, topical, mucosal introduction, and especially for aerosolised introduction in lungs.
50 cl, 3 dwg, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HIGH-DOSED LIPOSOME AEROSOL PHARMACEUTICAL COMPOSITIONS | 1997 |
|
RU2174390C2 |
| AQUEOUS AEROSOL PREPARATION | 2004 |
|
RU2363449C2 |
| AQUEOUS COMPOSITIONS CONTAINING ARBEKACINE | 2012 |
|
RU2604767C2 |
| RAPAMYCIN FOR TREATING LYMPHANGIOLEIOMYOMATOSIS | 2014 |
|
RU2707285C2 |
| INTRODUCTION OF ILOPROST IN FORM OF AEROSOL BOLUSES | 2012 |
|
RU2605849C2 |
| LIQUID PREPARATION CONTAINING TOBRAMYCINE | 2004 |
|
RU2341267C2 |
| TREATMENT OF PULMONARY INFECTIONS BY ADMINISTERING TOBRAMYCIN BY AEROLYSATION | 2011 |
|
RU2597842C2 |
| INHALATION DOSAGE FORM OF RAPAMYCIN FOR TREATING PULMONARY HYPERTENSION | 2015 |
|
RU2732908C2 |
| RAPAMYCIN-CONTAINING COMPOSITION ADMINISTERED BY INHALATION FOR TREATING AGE-RELATED DISEASES | 2015 |
|
RU2718583C2 |
| METHOD AND COMPOSITION FOR TREATMENT OF INFLAMMATORY DISORDERS | 2006 |
|
RU2468797C2 |
